TLDR:
- Ultrahuman, a wearable healthtech startup, raised USD 35 million in Series B funding.
- The funds will be used to enhance manufacturing capacity and conduct deeper research in the health tracking space.
The Bengaluru-based health monitoring device maker Ultrahuman secured USD 35 million in Series B funding from venture capital firms Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave Incubation, and Zomato founder Deepinder Goyal. The startup plans to allocate the funds towards expanding its manufacturing capacity and conducting in-depth research in health tracking. Founded in 2021 by Mohit Kumar and Vatsal Singhal, Ultrahuman manufactures fitness rings and products like Ring Air, M1 Live, Ultrahuman Home, and Blood Vision. The platform integrates various health data streams, including glucose, sleep, movement, blood markers, and HRV for comprehensive health monitoring.
Ultrahuman aims to become a top player in active devices globally, with products available in over 150 retail locations worldwide. The startup has completed a clinical trial with 105 participants to validate its ‘Metabolic Score’ and is set to generate significant revenue through its new manufacturing facility, UltraFactory. By 2024, Ultrahuman expects to achieve an annualized revenue run rate of over USD 100 million.
